Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 265, Issue 7, pp 791–796 | Cite as

The impact of radiotherapy and GERD on in situ lifetime of indwelling voice prostheses

  • Paolo Boscolo-Rizzo
  • Carlo Marchiori
  • Alessandro Gava
  • Maria Cristina Da Mosto
Laryngology

Abstract

The aim of this study was (1) to analyze the in situ lifetime of indwelling voice prostheses (VPs) and (2) to investigate the role of some variables on device lifetime. We conducted a retrospective clinical study of patients visiting our outpatient clinic for problems related to their VP from August 1998 to March 2006. The mean in situ VP lifetime was 180.9 days (95% CI 162.6–199.2). The mean in situ VP lifetime was 163.3 and 202.9 days in patients irradiated and not irradiated, respectively (P = 0.008). The mean in situ VP lifetime was 126.5 and 215.7 days in patients with and without endoscopic evidence of erosive-ulcerative gastroesophageal reflux disease (GERD), respectively (P < 0.001). Multivariate analysis confirmed that radiotherapy and presence of GERD significantly affected the in situ VP lifetime. This study confirmed the relationship between short VP lifetime and radiation therapy. In addition, a possible association between GERD and limited device lifetime was identified.

Keywords

Total laryngectomy Voice rehabilitation Voice prosthesis Radiotherapy GERD 

References

  1. 1.
    Terada T, Saeki N, Toh K, Uwa N, Sagawa K, Takayasu S, Sakagami M (2007) Voice rehabilitation with Provox2 voice prosthesis following total laryngectomy for laryngeal and hypopharyngeal carcinoma. Auris Nasus Larynx 34:65–71PubMedCrossRefGoogle Scholar
  2. 2.
    Hilgers FJ, Cornelissen MW, Balm AJ (1993) Aerodynamic characteristics of the Provox low-resistance indwelling voice prosthesis. Eur Arch Otorhinolaryngol 250:375–378PubMedCrossRefGoogle Scholar
  3. 3.
    Hilgers FJ, Ackerstaff AH, Balm AJ, Van den Brekel MW, Bing Tan I, Persson JO (2003) A new problem-solving indwelling voice prosthesis, eliminating the need for frequent Candida- and “underpressure”-related replacements: Provox ActiValve. Acta Otolaryngol 123:972–979PubMedCrossRefGoogle Scholar
  4. 4.
    Elving GJ, van der Mei HC, Busscher HJ, van Weissenbruch R, Albers FW (2002) Comparison of the microbial composition of voice prosthesis biofilms from patients requiring frequent versus infrequent replacement. Ann Otol Rhinol Laryngol 111:200–203PubMedGoogle Scholar
  5. 5.
    Shultz JR, Harrison J (1992) Defining and predicting tracheoesophageal puncture success. Arch Otolaryngol Head Neck Surg 118:811–816PubMedGoogle Scholar
  6. 6.
    Kao WW, Mohr RM, Kimmel CA, Getch C, Silverman C (1994) The outcome and techniques of primary and secondary tracheoesophageal puncture. Arch Otolaryngol Head Neck Surg 120:301–307PubMedGoogle Scholar
  7. 7.
    Makitie AA, Niemensivu R, Juvas A, Aaltonen LM, Back L, Lehtonen H (2003) Postlaryngectomy voice restoration using a voice prosthesis: a single institution’s ten-year experience. Ann Otol Rhinol Laryngol 112:1007–1010PubMedGoogle Scholar
  8. 8.
    Elving GJ, Van Weissenbruch R, Busscher HJ, Van Der Mei HC, Albers FW (2002) The influence of radiotherapy on the lifetime of silicone rubber voice prostheses in laryngectomized patients. Laryngoscope 112:1680–1683PubMedCrossRefGoogle Scholar
  9. 9.
    Delsupehe K, Zink I, Lejaegere M, Delaere P (1998) Prospective randomized comparative study of tracheoesophageal voice prosthesis: Blom–Singer versus Provox. Laryngoscope 108:1561–1565PubMedCrossRefGoogle Scholar
  10. 10.
    Laccourreye O, Menard M, Crevier-Buchman L, Couloigner V, Brasnu D (1997) In situ lifetime, causes for replacement, and complications of the Provox voice prosthesis. Laryngoscope 107:527–530PubMedCrossRefGoogle Scholar
  11. 11.
    Op de Coul BM, Hilgers FJ, Balm AJ, Tan IB, van den Hoogen FJ, van Tinteren H (2000) A decade of postlaryngectomy vocal rehabilitation in 318 patients: a single Institution’s experience with consistent application of provox indwelling voice prostheses. Arch Otolaryngol Head Neck Surg 126:1320–1328Google Scholar
  12. 12.
    Demir D, Suoglu Y, Emin H, Guven M, Kiyak E (2004) Factors that affect in situ lifetime of Provox voice prosthesis. Kulak Burun Bogaz Ihtis Derg 13:126–131PubMedGoogle Scholar
  13. 13.
    Leder SB, Erskine MC (1997) Voice restoration after laryngectomy: experience with the Blom–Singer extended-wear indwelling tracheoesophageal voice prosthesis. Head Neck 19:487–93PubMedCrossRefGoogle Scholar
  14. 14.
    Holmes AR, van der Wielen P, Cannon RD, Ruske D, Dawes P (2006) Candida albicans binds to saliva proteins selectively adsorbed to silicone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:488–494PubMedCrossRefGoogle Scholar
  15. 15.
    Ameye D, Honraet K, Loose D, Vermeersch H, Nelis H, Remon JP (2005) Effect of a buccal bioadhesive nystatin tablet on the lifetime of a Provox silicone tracheoesophageal voice prosthesis. Acta Otolaryngol 125:304–306PubMedCrossRefGoogle Scholar
  16. 16.
    Schwandt LQ, van Weissenbruch R, van der Mei HC, Busscher HJ, Albers FW (2005) Effect of dairy products on the lifetime of Provox2 voice prostheses in vitro and in vivo. Head Neck 27:471–477PubMedCrossRefGoogle Scholar
  17. 17.
    Leder SB, Acton LM, Kmiecik J, Ganz C, Blom ED (2005) Voice restoration with the advantage tracheoesophageal voice prosthesis. Otolaryngol Head Neck Surg 133:681–684PubMedCrossRefGoogle Scholar
  18. 18.
    Liu RP, Fleming TJ, Toth BB, Keene HJ (1990) Salivary flow rates in patients with head and neck cancer 0.5 to 25 years after radiotherapy. Oral Surg Oral Med Oral Pathol 70:724–729PubMedCrossRefGoogle Scholar
  19. 19.
    Lundell L (2007) Therapy of gastroesophageal reflux: evidence-based approach to antireflux surgery. Dig Dis 25:188–196PubMedCrossRefGoogle Scholar
  20. 20.
    Smout AJ (2007) The patient with GORD and chronically recurrent problems. Best Pract Res Clin Gastroenterol 21:365–378PubMedCrossRefGoogle Scholar
  21. 21.
    Metz DC, Inadomi JM, Howden CW, van Zanten SJ, Bytzer P (2007) On-demand therapy for gastroesophageal reflux disease. Am J Gastroenterol 102:642–653PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Paolo Boscolo-Rizzo
    • 1
    • 3
  • Carlo Marchiori
    • 1
  • Alessandro Gava
    • 2
  • Maria Cristina Da Mosto
    • 1
  1. 1.ENT Department and Regional Center for Head and Neck CancerUniversity of Padua, School of Medicine, Treviso Regional HospitalTrevisoItaly
  2. 2.Department of Radiation OncologyTreviso Regional HospitalTrevisoItaly
  3. 3.Chioggia, VeneziaItaly

Personalised recommendations